DMAC · CUSIP 25253X207
DIAMEDICA THERAPEUTICS INC
Reported by 1 of 79 curated managers in Q2 2026, in the holdings snapshot last exported 2026-10-26.
- Managers holding
- 1
- Average portfolio weight
- 0.7%
- Combined reported value
- $24.3M
- Research group
- 79
1 of the 79 superinvestors Shameless Cloning tracks reported DIAMEDICA THERAPEUTICS INC (DMAC) in their Q2 2026 13F filings, worth $24.3M combined, at an average 0.7% of their portfolios. The largest positions by portfolio weight belong to Leon Cooperman (0.7%).
Reporting managers
This is a historical 13F snapshot, not a live shareholder register. The count covers all matched managers; dashboard rankings use only those with at least 95% coverage. Reported value is measured at filing quarter-end, not at today's price.
| Manager / SEC filer | % of portfolio | Reported value |
|---|---|---|
| Leon CoopermanCOOPERMAN LEON G | 0.7% | $24.3M |